CVA
TECH icon

Ceredex Value Advisors’s Bio-Techne TECH Stock Holding History

Ceredex Value Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.49M Sell
120,139
-224,777
-65% -$12.1M 0.24% 160
2026
Q1 		$18M Sell
344,916
-343,405
-50% -$20.6M 0.57% 79
2025
Q4 		$40.5M Buy
+688,321
New +$41.8M 1.22% 9

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ceredex Value Advisors's TECH Position: Q2 2026 in Review

Ceredex Value Advisors reduced its Bio-Techne (TECH) stake by 65% in Q2 2026, selling an estimated $12.1M and leaving 120,139 shares worth $8.49M. The position accounts for 0.24% of the portfolio, ranked #160.

Ceredex Value Advisors first reported a position in TECH in Q4 2025 and has held it in 3 quarters since. The position peaked at $40.5M in Q4 2025. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Ceredex Value Advisors held 120,139 shares of Bio-Techne worth $8.49M as of Q2 2026.
  • Ceredex Value Advisors sold 224,777 Bio-Techne shares in Q2 2026, an estimated $12.1M.
  • Bio-Techne made up 0.24% of Ceredex Value Advisors's portfolio in Q2 2026, its #160 holding.
  • Ceredex Value Advisors first reported a position in Bio-Techne in Q4 2025 and has held it in 3 quarters since.
  • Ceredex Value Advisors's Bio-Techne position peaked at $40.5M in Q4 2025.
  • 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Ceredex Value Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.